SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-015596
Filing Date
2024-02-15
Accepted
2024-02-15 07:00:13
Documents
14
Period of Report
2024-02-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rnlx-20240215.htm   iXBRL 8-K 38801
2 EX-99.1 rnlx-ex99_1.htm EX-99.1 623635
3 GRAPHIC img102423453_0.jpg GRAPHIC 28770
  Complete submission text file 0000950170-24-015596.txt   878562

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rnlx-20240215.xsd EX-101.SCH 50833
16 EXTRACTED XBRL INSTANCE DOCUMENT rnlx-20240215_htm.xml XML 6091
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39387 | Film No.: 24642008
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)